Diabetes educators can help patients with diabetes who face financial challenges make appropriate choices and receive assistance to afford medications, said Kellie Rodriguez, RN, MSN, MBA, CDE, director, Global Diabetes Program, Parkland Health & Hospital System.
Diabetes educators can help patients with diabetes who face financial challenges make appropriate choices and receive assistance to afford medications, said Kellie Rodriguez, RN, MSN, MBA, CDE, director, Global Diabetes Program, Parkland Health & Hospital System.
What are some of the challenges diabetes educators anticipate as patients are asked to assume more financial responsibility for their care?
It’s a real privilege to be a diabetes educator. We really get to immerse ourselves in the lived world of the patient and the person living with diabetes. And with that comes a real responsibility. So, the self-care requirements—it’s a disease of self-care—the self-care requirements are extensive and they’re daily and they’re unrelenting. So, all the lifestyle requirements, the monitoring, the medication requirements, the visit requirements are all very costly, and so, what it does require us to do is start to think a little bit more creatively around prioritizing care and looking for strategies and solutions that may be less costly. Or being able to adapt our recommendations to the lived world of the patient.
So, if finances are a challenge and they’re living from the dollar menu, we need to be able to accommodate that and not say, “That’s not appropriate,” but look for appropriate choices in those sorts of areas. Same with medications, looking for prescription assistance programs to support some of the needs for people to be able to achieve the medications that they have. So, there’s a lot of different strategies that we need to be mindful of.
I think the key is to be able to assess it first and to recognize it’s a problem. And I think in healthcare we’re doing a better job of moving away from just clinical assessment to more of the lived world assessment to be able to better understand that’s a concern and be sure that we incorporate that in all of our strategies including pharmacotherapy choices. Sometimes the best pharmacotherapy choice may not be the best patient choice, but we’re going to make the best patient choice, because that’s what’s going to lead to the best outcomes.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More